The FTC is suing 2 drug companies
Advertisement
The Federal Trade Commission is going after two drug companies for obstructing generic drug competition.
Advertisement
The FTC is suing Endo International and Allergan, according to a complaint filed in a California Federal court on Monday. Endo was down 5% on the news Monday afternoon, while Allergan was slightly up. Teva, which acquired Allergan's generics business, was down 3%.
This isn't the first time the FTC has gone after Endo and Allergan. In March 2016, the agency sued both companies for blocking access to cheaper versions of Opana ER and Lidoderm, drugs used to treat pain.
This is developing.
Markets Insider
Advertisement
Advertisement
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- 2 states where home prices are falling because there are too many houses and not enough buyers
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- India Inc marks slowest quarterly revenue growth in January-March 2024: Crisil
- Nothing Phone (2a) India-exclusive Blue Edition launched starting at ₹19,999
- SC refuses to plea seeking postponement of CA exams scheduled in May
- 10 exciting weekend getaways from Delhi within 300 km in 2024
- Foreign tourist arrivals in India will cross pre-pandemic level in 2024